Daniel Nettersheim
Overview
Explore the profile of Daniel Nettersheim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Seidel C, Paulsen F, Nestler T, Cathomas R, Hentrich M, Paffenholz P, et al.
Virchows Arch
. 2023 Dec;
485(1):123-130.
PMID: 38097681
Approximately 30% of seminoma (SEM) patients present with moderately elevated human chorionic gonadotropin (hCG) levels at first diagnosis. In case of high hCG serum levels, the presence of a non-SEM...
12.
Wakileh G, Bierholz P, Kotthoff M, Skowron M, Bremmer F, Stephan A, et al.
Exp Hematol Oncol
. 2023 Nov;
12(1):96.
PMID: 37996954
Being stimulated by the chemokine CXCL12, the CXCR4 / CXCR7 cascade is involved in tumor proliferation, migration, and metastasis. The interaction between CXCL12, secreted by cells from the microenvironment, and...
13.
Bremmer F, Pongratanakul P, Skowron M, Che Y, Richter A, Kuffer S, et al.
Br J Cancer
. 2023 Sep;
129(10):1580-1589.
PMID: 37726478
Background: Germ cell tumors (GCT) might undergo transformation into a somatic-type malignancy (STM), resulting in a cell fate switch to tumors usually found in somatic tissues, such as rhabdomyosarcomas or...
14.
Bremmer F, Lubk L, Strobel P, Nettersheim D
Histopathology
. 2023 Jun;
83(3):477-481.
PMID: 37265221
Testicular germ cell tumours are the most common solid malignancies in young men of age 14-44 years. It is generally accepted that both seminomas and non-seminomas arise from a common...
15.
Sohngen C, Thomas D, Skowron M, Bremmer F, Eckstein M, Stefanski A, et al.
FEBS J
. 2023 May;
290(20):4864-4876.
PMID: 37254618
Alternative therapeutic options targeting urologic malignancies, such as germ cell tumours, as well as urothelial, renal and prostate carcinomas, are still urgently needed. The membrane protein CD24 represents a promising...
16.
Funke K, Einsfelder U, Hansen A, Arevalo L, Schneider S, Nettersheim D, et al.
Br J Cancer
. 2023 Apr;
128(12):2270-2282.
PMID: 37024667
Background: Type II testicular germ cell tumours (TGCT) are the most prevalent tumours in young men. Patients suffering from cisplatin-resistant TGCTs are facing very poor prognosis demanding novel therapeutic options....
17.
Skowron M, Kotthoff M, Bremmer F, Ruhnke K, Parmaksiz F, Richter A, et al.
Mol Med
. 2023 Mar;
29(1):40.
PMID: 36991316
Background: Being the standard-of-care for four decades, cisplatin-based chemotherapy is highly efficient in treating germ cell tumors (GCT). However, often refractory patients present with a remaining (resistant) yolk-sac tumor (YST(-R))...
18.
Burmeister A, Stephan A, Avelar L, Muller M, Seiwert A, Hofmann S, et al.
Mol Cancer Ther
. 2022 Aug;
21(11):1674-1688.
PMID: 35999659
Urological malignancies represent major challenges for clinicians, with annually rising incidences. In addition, cisplatin treatment induced long-term toxicities and the development of therapy resistance emphasize the need for novel therapeutics....
19.
Stephan A, Kotthoff M, Bremmer F, Nettersheim D
Pathologie (Heidelb)
. 2022 Aug;
43(6):409-415.
PMID: 35925316
Background: Germ cell tumors (GCTs) are the most common type of cancer in Germany in young men between 15 and 44 years of age. The routinely performed diagnostic procedures are...
20.
Skowron M, Eul K, Stephan A, Ludwig G, Wakileh G, Bister A, et al.
Mol Oncol
. 2022 Jul;
16(17):3107-3127.
PMID: 35811571
The tumor microenvironment (TM), consisting of the extracellular matrix (ECM), fibroblasts, endothelial cells, and immune cells, might affect tumor invasiveness and the outcome of standard chemotherapy. This study investigated the...